Progress in Molecular Biology and Translational Science, Vol 162

  • ID: 4659910
  • Book
  • 300 Pages
  • Elsevier Science and Technology
1 of 3

Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A, Volume 162 in the Progress in Molecular Biology and Translational Science series provides informative monographs on a variety of research topics related to Glycans and glycosaminoglycans as clinical biomarkers and therapeutics. Topics in this update include Glycan-based Biomarkers for Diagnosis of Cancers and Other Diseases: Past, Present and Future, Desialylation in Diseases and its Application in Diagnostic and Therapeutic Development, Proteoglycans as Miscommunication Biomarkers for Cancer Diagnosis, Fucosylation in Cancer Biology and Its Clinical Applications, Retrospective Analysis of Glycan-Related Biomarkers Based on Clinical Laboratory Data in Two Medical Centers, and many related topics.

  • Includes comprehensive coverage of molecular biology
  • Presents ample use of tables, diagrams, schemata and color figures to enhance the reader's ability to rapidly grasp the information provided
  • Contains contributions from renowned experts in the field
Note: Product cover images may vary from those shown
2 of 3
1. Glycan-based Biomarkers for Diagnosis of Cancers and Other Diseases: Past, Present and Future Minghui Hu 2. Desialylation in Diseases and its Application in Diagnostic and Therapeutic Development Mohui Wei 3. Proteoglycans as Miscommunication Biomarkers for Cancer Diagnosis Lingling Xu 4. Fucosylation in Cancer Biology and Its Clinical Applications Ming Shan 5. Retrospective Analysis of Glycan-Related Biomarkers Based on Clinical Laboratory Data in Two Medical Centers during the Past Seven years Meng Zhang 6. Serum SCCA Levels in Patients with Psoriasis, Cancers, or Other Diseases Dandan Yang 7. Increased Serum CA724 Levels in Patients Suffering Gout vs. Cancers Yiran Zhang 8. Serum CA50 Levels in Diagnosing Cancers and Other Diseases Ming Shan 9. Fasting Blood Glucose Levels in Patients with different Types of Diseases Qinghua Zhang 10. Serum AFP Levels are increased in Liver Cancer but Decreased in most types of Cancers and Diseases Huaiqian Dou 11. Serum CEA Levels in 54 Different Types of Diseases Cui Hao 12. CA242 as a Biomarker for Pancreatic Cancer and Other Diseases Yanli He 13. Serum CA125 Levels are decreased in Colorectal Cancers but Increased in Most Types of Cancers Meng Zhang 14. Serum CA199 level is significantly increased in patients suffering Liver Diseases Pengjiao Zeng 15. CA15-3 as a Biomarker for Cancer and other Types of Diseases Xiulian Li 16. Serum Glycated Albumin Level is Significantly Decreased in Patients with Different Types of Kidney Diseases Zhe Wang 17. Glycated Serum Proteins: Higher Level as a Biomarker for Pancreatic Cancer and the Lower Level as a Biomarker for Leukemia Xiaodan Huang 18. Higher HbAlc levels in Patients Suffering Pancreatitis Zhifeng Jiang 19. Sialic Acid as a General Biomarker for all Types of Diseases Xueling Wang 20. Combination of Different Glycan Biomarkers for Cancer Detection Yang Tang 21. Serum ?-L-fucosidase Levels are increased in all Types of Cancer Patients Meng Zhang
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll